Chiang-Wen Lee Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2023	Nanocurcumin Reduces High Glucose and Particulate Matter-Induced Endothelial Inflammation: Mitochondrial Function and Involvement of miR-221/222.
1/2022	Combined exposure to fine particulate matter and high glucose aggravates endothelial damage by increasing inflammation and mitophagy: the involvement of vitamin D.
1/2017	CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiang-Wen Lee Research Topics

Disease

31	Inflammation (Inflammations) 06/2023 - 12/2005
13	Neoplasms (Cancer) 01/2024 - 01/2014
6	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 01/2019
6	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
6	Infections 06/2022 - 08/2009
5	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2018
5	Pneumonia (Pneumonitis) 07/2022 - 01/2010
5	Melanoma (Melanoma, Malignant) 09/2018 - 12/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 04/2017
4	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2023 - 01/2013
4	Skin Diseases (Skin Disease) 01/2020 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2017
3	Ischemia 01/2021 - 01/2017
3	Septic Shock (Toxic Shock Syndrome) 01/2018 - 08/2015
2	Hyperglycemia 01/2023 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2019
2	Osteoarthritis 01/2021 - 11/2019
2	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Atopic Dermatitis (Atopic Eczema) 08/2019 - 01/2018
2	Atherosclerosis 03/2017 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 05/2016 - 01/2015
2	Bacteremia 01/2015 - 02/2014
2	Dermatitis 01/2014 - 01/2012
2	Melanosis (Freckles) 01/2014 - 01/2012
2	Hyperpigmentation 01/2014 - 01/2012
2	Sunburn 10/2013 - 02/2013
2	Gram-Positive Bacterial Infections 04/2010 - 10/2008
1	Subdural Empyema 04/2024

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2005
12	Particulate MatterIBA 01/2023 - 01/2016
12	AntioxidantsIBA 07/2022 - 01/2010
8	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023 - 01/2016
7	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 02/2014
7	artocarpin lectinIBA 05/2019 - 10/2013
6	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2017
6	FlavonoidsIBA 05/2019 - 10/2013
5	CytokinesIBA 09/2023 - 12/2005
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2019 - 01/2010
5	Melanins (Melanin)IBA 09/2018 - 01/2012
5	eupafolinIBA 08/2016 - 01/2014
4	Phospholipases (Phospholipase)IBA 01/2023 - 04/2010
4	tricarbonyldichlororuthenium (II) dimerIBA 01/2022 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 06/2021 - 08/2009
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021 - 03/2017
4	Monophenol Monooxygenase (Tyrosinase)IBA 09/2018 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 06/2008
4	ProstaglandinsIBA 08/2011 - 01/2010
3	Matrix Metalloproteinases (MMPs)IBA 06/2023 - 06/2007
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023 - 01/2017
3	Therapeutic UsesIBA 07/2022 - 06/2013
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 06/2013
3	Methanol (Carbinol)IBA 01/2015 - 01/2014
2	naringeninIBA 01/2024 - 01/2022
2	Annexin A5IBA 01/2024 - 01/2021
2	LigandsIBA 01/2023 - 08/2020
2	Air Pollutants (Pollutants, Air)IBA 01/2023 - 08/2016
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
2	EnzymesIBA 01/2023 - 01/2018
2	C-Reactive ProteinIBA 06/2022 - 08/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2010
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2020
2	InflammasomesIBA 08/2021 - 01/2019
2	Conditioned Culture MediaIBA 01/2021 - 02/2020
2	Fibronectins (Fibronectin)IBA 01/2021 - 06/2013
2	Environmental Pollutants (Pollutants, Environmental)IBA 09/2020 - 01/2018
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2020 - 06/2013
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2017
2	Dinoprostone (PGE2)FDA Link 08/2019 - 01/2016
2	CaspasesIBA 01/2019 - 09/2018
2	CurcuminIBA 01/2019 - 01/2013
2	Cytochromes c (Cytochrome c)IBA 01/2019 - 02/2016
2	3',4',7-trihydroxyisoflavoneIBA 01/2018 - 01/2016
2	daidzeinIBA 01/2018 - 01/2016
2	magnololIBA 03/2017 - 01/2014
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 06/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 06/2013
2	Phospholipases A2 (Phospholipase A2)IBA 10/2013 - 02/2013
2	Arachidonic Acid (Vitamin F)IBA 08/2011 - 04/2010
2	Prostaglandins EIBA 04/2010 - 01/2010
2	lipoteichoic acidIBA 04/2010 - 10/2008
1	Coloring Agents (Dyes)IBA 01/2024
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2024
1	flavanoneIBA 01/2024
1	Acridine OrangeIBA 01/2024
1	acetylshikoninIBA 12/2023
1	tanshinoneIBA 06/2023
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 01/2023
1	MitoSox RedIBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Protein Kinases (Protein Kinase)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	ChemokinesIBA 01/2023
1	Chemokine Receptor D6IBA 01/2023

Therapy/Procedure

9	Therapeutics 08/2021 - 02/2014
4	Drug Therapy (Chemotherapy) 01/2023 - 05/2016
2	Radiotherapy 01/2022 - 01/2019
2	Replacement Arthroplasty 01/2019 - 01/2018
2	Traditional Medicine (Folk Remedies) 01/2014 - 01/2012